Choosing Measurement Windows For Time-Updated Omics

Why Measurement Windows Change the Question

An omics assay is a measurement taken at a particular time; a time-updated Cox model needs a covariate value available throughout each subject's risk time. Turning intermittent assays into a time-varying predictor therefore requires a rule for which part of the observed history represents the exposure at each time. That rule is not just a data-processing detail. It defines the exposure history whose association with the hazard is being estimated.

A recent assay may be the most relevant measure if the molecular state changes rapidly. A moving average may better represent sustained activity, while a lag may be appropriate when a molecular change is expected to precede a clinical event by a delay. These choices can produce different estimates even when they use the same underlying assay records.

Three Ways to Define a Time-Updated Covariate

For assays collected at times \(s_{i1},s_{i2},\ldots\), the last-observation value is

It is often implemented by carrying the most recent value forward until another assay is available. The strict inequality makes the timing convention explicit: a result obtained at the event time should not predict that event unless it was available before the event. A moving average over a trailing window of width \(w\) can be defined as a time-weighted average,

This integral requires a defined history between assays, such as a prespecified piecewise-constant interpolation. It is different from simply averaging the assay records in the interval: an unweighted average gives each assay equal weight even when the gaps between assays differ. A lagged covariate is \(X_i^{\mathrm{lag}}(t;\ell)=X_i(t-\ell)\) when the value at \(t-\ell\) is observed. With intermittent assays, an analysis must specify how it obtains that historical value, for example by using the latest assay available at or before \(t-\ell\). Each definition must use only information available before the event time.

Model and Interpretation

For any chosen window rule \(W\), a time-updated Cox model can be written as

Here \(\lambda_i(t\mid \mathcal{F}_{i,t-})\) is subject \(i\)'s hazard at time \(t\), conditional on the observed history available just before \(t\); \(\lambda_0(t)\) is the unspecified baseline hazard; and \(X_i^W(t)\) is the covariate defined by the selected window. The model assumes that the log hazard is linear in this covariate and that its coefficient \(\beta\) is constant over time: conditional on the model covariates, a one-unit difference in \(X_i^W(t)\) corresponds to a hazard ratio of \(\exp(\beta)\). It also requires appropriate handling of censoring and correctly ordered covariate histories. A causal interpretation needs additional assumptions and a design that supports it; the model alone establishes an association, not a causal effect.

The window changes the meaning of \(\beta\). With the last observation, it describes the association with the most recently measured level as carried forward. With a moving average, it describes the association with a sustained or recent average over the specified duration. With a lag, it describes the association with an earlier molecular value at the chosen delay. A one-unit contrast in these predictors is not necessarily the same biological contrast.

Why These Rules Estimate Different Associations

The Cox partial likelihood makes the role of the predictor explicit. At an event time \(t_j\), the contribution for the subject \(i_j\) who experiences the event is proportional to that subject's relative hazard among the subjects still at risk:

Here \(R(t_j)\) is the risk set just before \(t_j\). Replacing a last observation with a moving average or a lag changes the covariate values inside these comparisons, and therefore changes the partial likelihood and its fitted coefficient. The estimate is tied to the exposure-history summary used in the model; it is not a window-free property of the assay.

For instance, if risk is related to a brief rise immediately before an event, a long moving average can dilute that rise. If risk is more closely associated with accumulated molecular activity, a single latest value can be a noisy representation of the relevant history. A lag shifts the association to an earlier time, but a poorly chosen lag may miss the relevant period altogether.

The moving-average formula also shows why gaps matter. If an assay value is treated as constant between measurements, each value contributes in proportion to the length of time it covers in the window. That calculation is transparent, but the interpolation is an analysis convention, not proof that the underlying biology was constant.

Lagging for Biological Latency

A lag is useful when the scientific hypothesis specifies that a molecular state precedes, rather than coincides with, a change in hazard. The lag length should be chosen in advance when possible and justified using biological knowledge or a clearly specified analysis plan. Searching many lags and reporting only the strongest association can exaggerate evidence and make the selected estimate difficult to interpret.

Choosing, Comparing, and Checking Windows

The comparison should be driven by the biological and clinical question, not by which specification produces the smallest p-value. Useful checks include plotting assay times and values against event and censoring times; verifying that each risk-set covariate uses only assays already available; checking how often a carried-forward value is old; and examining whether conclusions change under a small set of scientifically plausible windows. Large changes across windows are evidence that the hazard association depends on how history is summarized, not a reason to select a preferred result after the fact.

Also check the model's proportional-hazards assumption for the chosen covariate. If the association changes over follow-up, a single coefficient may average over different effects. Unequal or symptom-driven assay schedules deserve special attention: people who become unwell may be tested more frequently, and measurement timing can then track evolving health. A standard time-updated Cox model does not automatically remove this concern. Addressing the visit process requires methods beyond simply choosing a window.

Window choice has limits. Last observation does not recover unobserved changes between assays; moving averages depend on window width and the assumed history between observations; and a lag cannot identify latency if the relevant earlier values are unavailable. These rules summarize observed data. They do not solve measurement error, establish causal effects, or substitute for a model of the assay process.

Common Mistake